Abstract
The La protein is an essential RNA-binding protein implicated in different aspects of RNA metabolism. Herein, we report that small interfering (siRNA)-mediated La depletion reduces cell proliferation of different cell lines concomitant with a reduction in cyclin D1 (CCND1) protein. To exclude off-target effects we demonstrate that exogenous La expression in La-depleted cells restores cell proliferation and CCND1 protein levels. In contrast, proliferation of immortalized CCND1 knockout cells is not affected by La depletion, supporting a functional coherence between La, CCND1 and proliferation. Furthermore, we document by reversible in vivo crosslinking and ribonucleoprotein (RNP) immunoprecipitation an association of the La protein with CCND1 messengerRNA and that CCND1 internal ribosome entry site (IRES)-dependent translation is modulated by La protein level within the cell. In addition, we show elevated La protein expression in cervical cancer tissue and its correlation with aberrant CCND1 protein levels in cervical tumor tissue lysates. In conclusion, this study establishes a role of La in cell proliferation and CCND1 expression and demonstrates for the first time an overexpression of the RNA-binding protein La in solid tumors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- CCND1:
-
cyclin D1
- con:
-
control
- FACS:
-
fluorescence-activated cell sorting
- GAPDH:
-
glyceraldehyde 3-phosphate dehydrogenase
- GFP:
-
green fluorescent protein
- MEF:
-
mouse embryonic fibroblasts
- PARP:
-
poly (ADP-ribose) polymerase
- siRNA:
-
small interfering RNA
- TMA:
-
tissue micro array
- XIAP:
-
X-linked inhibitor of apoptosis
- IRES:
-
internal ribosome entry site
References
Al-Ejeh F, Darby JM, Brown MP . (2007). The La autoantigen is a malignancy-associated cell death target that is induced by DNA-damaging drugs. Clin Cancer Res 13: 5509s–5518s.
Albanese C, D′Amico M, Reutens AT, Fu M, Watanabe G, Lee RJ et al. (1999). Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J Biol Chem 274: 34186–34195.
Ali N, Pruijn GJ, Kenan DJ, Keene JD, Siddiqui A . (2000). Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation. J Biol Chem 275: 27531–27540.
Bae DS, Cho SB, Kim YJ, Whang JD, Song SY, Park CS et al. (2001). Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol 81: 341–347.
Belsham GJ, Sonenberg N, Svitkin YV . (1995). The role of the La autoantigen in internal initiation. Curr Top Microbiol Immunol 203: 85–98.
Brenet F, Dussault N, Borch J, Ferracci G, Delfino C, Roepstorff P et al. (2005). Mammalian peptidylglycine alpha-amidating monooxygenase mRNA expression can be modulated by the La autoantigen. Mol Cell Biol 25: 7505–7521.
Brenet F, Socci ND, Sonenberg N, Holland EC . (2009). Akt phosphorylation of La regulates specific mRNA translation in glial progenitors. Oncogene 28: 128–139.
Calkhoven CF, Muller C, Leutz A . (2000). Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes Dev 14: 1920–1932.
Carreras R, Alameda F, Mancebo G, Garcia-Moreno P, Marinoso ML, Costa C et al. (2007). A study of Ki-67, c-erbB2 and cyclin D-1 expression in CIN-I, CIN-III and squamous cell carcinoma of the cervix. Histol Histopathol 22: 587–592.
Chang YN, Kenan DJ, Keene JD, Gatignol A, Jeang KT . (1995). Direct interactions between autoantigen la and human immunodeficiency virus leader RNA. J Virol 69: 618–619.
Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC et al. (1992). Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci USA 89: 4549–4553.
Cheung TH, Yu MM, Lo KW, Yim SF, Chung TK, Wong YF . (2001). Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix. Cancer Lett 166: 199–206.
Conesa-Zamora P, Domenech-Peris A, Orantes-Casado FJ, Ortiz-Reina S, Sahuquillo-Frias L, Acosta-Ortega J et al. (2009). Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study. Am J Clin Pathol 132: 378–390.
Cordes S, Kusov Y, Heise T, Gauss-Muller V . (2008). La autoantigen suppresses IRES-dependent translation of the hepatitis A virus. Biochem Biophys Res Commun 368: 1014–1019.
Costa-Mattioli M, Svitkin Y, Sonenberg N . (2004). La autoantigen is necessary for optimal function of the poliovirus and hepatitis C virus internal ribosome entry site in vivo and in vitro. Mol Cell Biol 24: 6861–6870.
Cowling VH . (2010). Enhanced mRNA cap methylation increases cyclin D1 expression and promotes cell transformation. Oncogene 29: 930–936.
Crosio C, Boyl PP, Loreni F, Pierandrei-Amaldi P, Amaldi F . (2000). La protein has a positive effect on the translation of top mRNAs in vivo. Nucl Acids Res 28: 2927–2934.
Diehl JA . (2002). Cycling to cancer with cyclin D1. Cancer Biol Ther 1: 226–231.
Ehlers I, Horke S, Reumann K, Rang A, Grosse F, Will H et al. (2004). Functional characterization of the interaction between human La and hepatitis B virus RNA. J Biol Chem 279: 43437–43447. Epub 2004 Aug 9.
Frost P, Shi Y, Hoang B, Gera J, Lichtenstein A . (2009). Regulation of D-cyclin translation inhibition in myeloma cells treated with mammalian target of rapamycin inhibitors: rationale for combined treatment with extracellular signal-regulated kinase inhibitors and rapamycin. Mol Cancer Ther 8: 83–93.
Fu M, Wang C, Li Z, Sakamaki T, Pestell RG . (2004). Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145: 5439–5447.
Holcik M, Korneluk RG . (2000). Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation. Mol Cell Biol 20: 4648–4657.
Horke S, Reumann K, Schweizer M, Will H, Heise T . (2004). Nuclear trafficking of La protein depends on a newly identified nucleolar localization signal and the ability to bind RNA. J Biol Chem 279: 26563–26570.
Inge LJ, Rajasekaran SA, Wolle D, Barwe SP, Ryazantsev S, Ewing CM et al. (2008). alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling. Mol Cancer Ther 7: 1386–1397.
Jo OD, Martin J, Bernath A, Masri J, Lichtenstein A, Gera J . (2008). Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function through Akt signaling. J Biol Chem 283: 23274–23287.
Kim YK, Back SH, Rho J, Lee SH, Jang SK . (2001). La autoantigen enhances translation of BiP mRNA. Nucleic Acids Res 29: 5009–5016.
Knudsen KE, Diehl JA, Haiman CA, Knudsen ES . (2006). Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25: 1620–1628.
Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS et al. (2003). A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114: 323–334.
Maraia RJ . (2001). La protein and the trafficking of nascent RNA polymerase iii transcripts. J Cell Biol 153: F13–F18.
Maraia RJ, Intine RV . (2002). La protein and its associated small nuclear and nucleolar precursor RNAs. Gene Expr 10: 41–57.
McLaren R, Caruccio N, Ross J . (1997). Human La protein: a stabilizer of histone mRNA. Mol Cell Biol 17: 3028–3036.
McLaughlin-Drubin ME, Munger K . (2009). The human papillomavirus E7 oncoprotein. Virology 384: 335–344.
Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM et al. (1991). A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350: 512–515.
Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N . (1998). Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem 273: 29864–29872.
Musgrove EA . (2006). Cyclins: roles in mitogenic signaling and oncogenic transformation. Growth Factors 24: 13–19.
Nerlov C . (2007). The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol 17: 318–324.
Nichols GE, Williams ME, Gaffey MJ, Stoler MH . (1996). Cyclin D1 gene expression in human cervical neoplasia. Mod Pathol 9: 418–425.
Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco MA . (2002). Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods 26: 182–190.
Park JM, Kohn MJ, Bruinsma MW, Vech C, Intine RV, Fuhrmann S et al. (2006). The multifunctional RNA-binding protein La is required for mouse development and for the establishment of embryonic stem cells. Mol Cell Biol 26: 1445–1451.
Pudi R, Srinivasan P, Das S . (2004). La protein binding at the GCAC site near the initiator AUG facilitates the ribosomal assembly on the hepatitis C virus RNA to influence internal ribosome entry site-mediated translation. J Biol Chem 279: 29879–29888.
Sebastian T, Malik R, Thomas S, Sage J, Johnson PF . (2005). C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence. Embo J 24: 3301–3312.
Shi Y, Sharma A, Wu H, Lichtenstein A, Gera J . (2005). Cyclin D1 and c-myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK- and ERK-dependent pathway. J Biol Chem 280: 10964–10973.
Spangberg K, Wiklund L, Schwartz S . (2001). Binding of the La autoantigen to the hepatitis C virus 3′ untranslated region protects the RNA from rapid degradation in vitro. J Gen Virol 82: 113–120.
Svitkin YV, Pause A, Sonenberg N . (1994). La autoantigen alleviates translational repression by the 5′ leader sequence of the human immunodeficiency virus type 1 mRNA. J Virol 68: 7001–7007.
Trotta R, Vignudelli T, Candini O, Intine RV, Pecorari L, Guerzoni C et al. (2003). BCR/ABL activates mdm2 mRNA translation via the La antigen. Cancer Cell 3: 145–160.
Wang C, Pattabiraman N, Zhou JN, Fu M, Sakamaki T, Albanese C et al. (2003). Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation. Mol Cell Biol 23: 6159–6173.
Wolin SL, Cedervall T . (2002). The La protein. Annu Rev Biochem 71: 375–403.
Zahnow CA . (2009). CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases. Expert Rev Mol Med 11: e12.
Acknowledgements
We thank Arne Düsedau (HPI) for sorting GFP-positive cells and Rick Peppler for FACS analysis (MUSC). We are grateful to R G Pestell (Thomas Jefferson University) for providing the MEFCCND1−/− cells, to M Bachmann (Technical University Dresden, Germany) for providing La antibodies, to Josef Gera for providing the CCND1-IRES reporter plasmid pRCD1F, to D Watson (MUSC) for experimental advice during this study, and D Fernandes (MUSC) and J Schnellmann (MUSC) for critical reading of the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft, HE 2814/3-2 (TH). The Heinrich-Pette-Institut (HPI) is financially supported by the Bundesministerium für Gesundheit and Freie und Hansestadt Hamburg.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website ()
Rights and permissions
About this article
Cite this article
Sommer, G., Dittmann, J., Kuehnert, J. et al. The RNA-binding protein La contributes to cell proliferation and CCND1 expression. Oncogene 30, 434–444 (2011). https://doi.org/10.1038/onc.2010.425
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.425
Keywords
This article is cited by
-
Cell surface-bound La protein regulates the cell fusion stage of osteoclastogenesis
Nature Communications (2023)
-
STAU2 protein level is controlled by caspases and the CHK1 pathway and regulates cell cycle progression in the non-transformed hTERT-RPE1 cells
BMC Molecular and Cell Biology (2021)
-
Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models
Molecular Imaging and Biology (2021)
-
LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression
Oncogene (2015)
-
The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®
EJNMMI Research (2014)